Protein Kinase C Inhibitors Arrest the C6 Glioma Cell Cycle at a Mid-G1 Phase Restriction Point : Implications for the Antiproliferative Action of Valproate

Lade...
Vorschaubild
Dateien
OBrien_1998.pdf
OBrien_1998.pdfGröße: 490.75 KBDownloads: 517
Datum
1997
Autor:innen
O'Brien, Evelyn
Regan, Ciaran M.
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Green
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Toxicology in vitro. 1997, 12(1), pp. 9-14. ISSN 0887-2333. Available under: doi: 10.1016/S0887-2333(97)00103-3
Zusammenfassung

The teratogenic mechanism(s) of valproate (VPA) have been suggested to arise through inhibition of proliferation coupled with differentiation at a mid-G1 phase restriction point in the cell cycle. As protein kinase C (PKC) plays a pivotal role in cell proliferation and differentiation, the effect of inhibitors specific for the catalytic and regulatory domains on transit through the G1 phase of the cell cycle was determined. Calphostin C and bisindolylmaleimide GF 109203X produced a dose-dependent decrease in proliferation of C6 glioma with approximate 50% inhibitory concentration values of 10 nImage and 1 μImage, respectively. Flow cytometric analysis indicated proliferative arrest to be in the G1 phase with the expected concomitant decrease of cells in the G2/M and S phases. Following release from drug-induced proliferative arrest, cells exhibited a synchronous entry into S phase as evidenced by an increase in [3H]thymidine incorporation after approximately 6-8 hr, indicating the restriction point to be in the mid-G1 phase. Using mitotically synchronized cells continuously exposed to valproate (2 mImage), PKC activity was found to be significantly reduced in the mid-G1 phase (5.5 hr) but not at an earlier (2.5 hr) time point, implying VPA to exert its effect at a site upstream to the point of proliferative arrest at 5-6 hr into the G1 phase which as yet, remains to be defined.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
Konferenz
Rezension
undefined / . - undefined, undefined
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Datensätze
Zitieren
ISO 690O'BRIEN, Evelyn, Ciaran M. REGAN, 1997. Protein Kinase C Inhibitors Arrest the C6 Glioma Cell Cycle at a Mid-G1 Phase Restriction Point : Implications for the Antiproliferative Action of Valproate. In: Toxicology in vitro. 1997, 12(1), pp. 9-14. ISSN 0887-2333. Available under: doi: 10.1016/S0887-2333(97)00103-3
BibTex
@article{OBrien1997Prote-8333,
  year={1997},
  doi={10.1016/S0887-2333(97)00103-3},
  title={Protein Kinase C Inhibitors Arrest the C6 Glioma Cell Cycle at a Mid-G1 Phase Restriction Point : Implications for the Antiproliferative Action of Valproate},
  number={1},
  volume={12},
  issn={0887-2333},
  journal={Toxicology in vitro},
  pages={9--14},
  author={O'Brien, Evelyn and Regan, Ciaran M.}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/8333">
    <dc:contributor>Regan, Ciaran M.</dc:contributor>
    <dc:rights>Attribution-NonCommercial-NoDerivs 2.0 Generic</dc:rights>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:42:45Z</dcterms:available>
    <dc:format>application/pdf</dc:format>
    <dc:creator>O'Brien, Evelyn</dc:creator>
    <dcterms:bibliographicCitation>First publ. in: Toxicology in vitro 12 (1998), 1, pp. 9-14</dcterms:bibliographicCitation>
    <dc:language>eng</dc:language>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:42:45Z</dc:date>
    <dcterms:abstract xml:lang="eng">The teratogenic mechanism(s) of valproate (VPA) have been suggested to arise through inhibition of proliferation coupled with differentiation at a mid-G1 phase restriction point in the cell cycle. As protein kinase C (PKC) plays a pivotal role in cell proliferation and differentiation, the effect of inhibitors specific for the catalytic and regulatory domains on transit through the G1 phase of the cell cycle was determined. Calphostin C and bisindolylmaleimide GF 109203X produced a dose-dependent decrease in proliferation of C6 glioma with approximate 50% inhibitory concentration values of 10 nImage and 1 μImage, respectively. Flow cytometric analysis indicated proliferative arrest to be in the G1 phase with the expected concomitant decrease of cells in the G2/M and S phases. Following release from drug-induced proliferative arrest, cells exhibited a synchronous entry into S phase as evidenced by an increase in [3H]thymidine incorporation after approximately 6-8 hr, indicating the restriction point to be in the mid-G1 phase. Using mitotically synchronized cells continuously exposed to valproate (2 mImage), PKC activity was found to be significantly reduced in the mid-G1 phase (5.5 hr) but not at an earlier (2.5 hr) time point, implying VPA to exert its effect at a site upstream to the point of proliferative arrest at 5-6 hr into the G1 phase which as yet, remains to be defined.</dcterms:abstract>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/8333"/>
    <dc:contributor>O'Brien, Evelyn</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/8333/1/OBrien_1998.pdf"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:title>Protein Kinase C Inhibitors Arrest the C6 Glioma Cell Cycle at a Mid-G1 Phase Restriction Point : Implications for the Antiproliferative Action of Valproate</dcterms:title>
    <dc:creator>Regan, Ciaran M.</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/8333/1/OBrien_1998.pdf"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:issued>1997</dcterms:issued>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by-nc-nd/2.0/"/>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Begutachtet
Diese Publikation teilen